• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙型肝炎相关肝细胞癌的肝切除术:超重和肥胖患者的临床结局与安全性

Liver resection in hepatitis B-related hepatocellular carcinoma: clinical outcomes and safety in overweight and obese patients.

作者信息

Wang Haiqing, Yang Jian, Zhang Xiaowu, Yan Lunan, Yang Jiayin

机构信息

Department of Liver Surgery, West China Hospital of Sichuan University, Chengdu, China.

出版信息

PLoS One. 2014 Jun 10;9(6):e99281. doi: 10.1371/journal.pone.0099281. eCollection 2014.

DOI:10.1371/journal.pone.0099281
PMID:24914932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4051674/
Abstract

OBJECTIVE AND BACKGROUND

Although many studies on evaluating the safety of liver resection in obese patients have been conducted, the results remain contradictory. The aim of our study was to investigate the safety of overweight and obese patients undergoing liver resection for hepatitis B-related hepatocellular carcinoma in a large sample.

METHODS

In a retrospective cohort with 1543 hepatitis B-related hepatocellular carcinoma patients, the subjects were stratified into four groups according to their body mass index(BMI): obesity(BMI≥28), overweight(BMI:24.0-27.9), normal weight(BMI:18.5-23.9) and underweight(BMI<18.5). The Dindo-Clavien classification system was used for grading complications. Clinical characteristics and operative outcomes were compared among the four groups. Risk factors for postoperative complications were evaluated by multivariate analysis.

RESULTS

According to the category criteria of the Working Group on Obesity in China (WGOC) criteria, 73(4.7%) obese, 412(26.7%) overweight, 982(63.6%) normal weight and 76(4.9%) underweight patients were included in our cohort. Overweight and obese patients had more preoperative comorbidities such as hypertension(P<0.001). Mortality, total complications and complications classified by Clavien system were similar among the four groups except that the underweight patients had fewer total complications. However, postoperative wound complication was more common in overweight and obese patients(6.3% vs 2.5%,P<0.001,11.0% vs 2.5%,P = 0.001). Multivariate analysis revealed that BMI was not an independently significant factor for postoperative complications.

CONCLUSIONS

Liver resection for obese and overweight patients is safe and BMI itself is not a risk factor for mortality and morbidity.

摘要

目的与背景

尽管已经开展了许多关于评估肥胖患者肝切除安全性的研究,但结果仍相互矛盾。我们研究的目的是在大样本中调查超重和肥胖患者接受乙型肝炎相关肝细胞癌肝切除的安全性。

方法

在一个包含1543例乙型肝炎相关肝细胞癌患者的回顾性队列中,根据体重指数(BMI)将受试者分为四组:肥胖(BMI≥28)、超重(BMI:24.0 - 27.9)、正常体重(BMI:18.5 - 23.9)和体重过轻(BMI<18.5)。采用Dindo-Clavien分类系统对并发症进行分级。比较四组患者的临床特征和手术结果。通过多变量分析评估术后并发症的危险因素。

结果

根据中国肥胖问题工作组(WGOC)标准的分类标准,我们的队列中包括73例(4.7%)肥胖患者、412例(26.7%)超重患者、982例(63.6%)正常体重患者和76例(4.9%)体重过轻患者。超重和肥胖患者术前合并症更多,如高血压(P<0.001)。除体重过轻患者的总并发症较少外,四组患者的死亡率、总并发症以及根据Clavien系统分类的并发症相似。然而,超重和肥胖患者术后伤口并发症更为常见(6.3%对2.5%,P<0.001;11.0%对2.5%,P = 0.001)。多变量分析显示,BMI不是术后并发症的独立显著因素。

结论

肥胖和超重患者的肝切除是安全的,BMI本身不是死亡率和发病率的危险因素。

相似文献

1
Liver resection in hepatitis B-related hepatocellular carcinoma: clinical outcomes and safety in overweight and obese patients.乙型肝炎相关肝细胞癌的肝切除术:超重和肥胖患者的临床结局与安全性
PLoS One. 2014 Jun 10;9(6):e99281. doi: 10.1371/journal.pone.0099281. eCollection 2014.
2
Liver resection in hepatitis B related-hepatocellular carcinoma: clinical outcomes and safety in elderly patients.乙型肝炎相关肝细胞癌的肝切除术:老年患者的临床结局与安全性
World J Gastroenterol. 2014 Jun 7;20(21):6620-5. doi: 10.3748/wjg.v20.i21.6620.
3
The impact of body mass index on short-term and long-term surgical outcomes of laparoscopic hepatectomy in liver carcinoma patients: a retrospective study.体重指数对肝癌患者腹腔镜肝切除术近期和远期手术结局的影响:一项回顾性研究。
World J Surg Oncol. 2022 May 10;20(1):150. doi: 10.1186/s12957-022-02614-1.
4
Influence of diabetes on short-term outcome after major hepatectomy: an underestimated risk?糖尿病对肝切除术近期预后的影响:被低估的风险?
BMC Surg. 2020 Nov 30;20(1):305. doi: 10.1186/s12893-020-00971-w.
5
Safety of liver resections in obese and overweight patients.肥胖和超重患者肝切除术的安全性。
World J Surg. 2010 Dec;34(12):2960-8. doi: 10.1007/s00268-010-0756-1.
6
Major hepatectomy is safe for hepatocellular carcinoma in elderly patients with cirrhosis.大肝切除术治疗老年肝硬化肝细胞癌是安全的。
Eur J Gastroenterol Hepatol. 2014 Apr;26(4):444-51. doi: 10.1097/MEG.0000000000000046.
7
Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.建立预测 Child-Pugh B 级肝硬化肝癌患者肝切除术后结局的列线图。
J Hepatol. 2020 Jan;72(1):75-84. doi: 10.1016/j.jhep.2019.08.032. Epub 2019 Sep 6.
8
Association between body mass index and postoperative morbidity after liver resection of hepatocellular carcinoma: A multicenter study of 1,324 patients.体重指数与肝细胞癌肝切除术后并发症的关系:一项多中心 1324 例患者的研究。
HPB (Oxford). 2020 Feb;22(2):289-297. doi: 10.1016/j.hpb.2019.06.021. Epub 2019 Aug 9.
9
Influence of obesity on in-hospital and postoperative outcomes of hepatic resection for malignancy: a 10-year retrospective analysis from the US National Inpatient Sample.肥胖对恶性肿瘤肝切除术后住院及预后的影响:来自美国国家住院样本的10年回顾性分析
BMJ Open. 2019 Aug 27;9(8):e029823. doi: 10.1136/bmjopen-2019-029823.
10
Safety of hepatic resection in overweight and obese patients with cirrhosis.肝切除术治疗超重和肥胖合并肝硬化患者的安全性。
Br J Surg. 2011 Aug;98(8):1147-54. doi: 10.1002/bjs.7516. Epub 2011 Apr 20.

引用本文的文献

1
Effect of Body Mass Index on Intraoperative Complications During Hepatic Resection for Malignancy.体重指数对恶性肿瘤肝切除术中并发症的影响。
ANZ J Surg. 2025 Jul-Aug;95(7-8):1462-1469. doi: 10.1111/ans.70250. Epub 2025 Jul 11.
2
Body mass index is a risk factor for postoperative morbidity after laparoscopic hepatectomy of hepatocellular carcinoma: a multicenter retrospective study.体质指数是腹腔镜肝癌切除术术后发病率的一个风险因素:一项多中心回顾性研究。
J Cancer Res Clin Oncol. 2024 Oct 5;150(10):445. doi: 10.1007/s00432-024-05979-w.
3
Preoperative Weight Loss Program for Hepatocellular Carcinoma Patients with High Body Mass Index in Hepatectomy.术前体重管理对合并肥胖的肝细胞癌患者行肝切除术的影响
World J Surg. 2023 Dec;47(12):3348-3355. doi: 10.1007/s00268-023-07220-0. Epub 2023 Oct 15.
4
Superiority of laparoscopic liver resection to open liver resection in obese individuals with hepatocellular carcinoma: A retrospective study.肥胖肝细胞癌患者行腹腔镜肝切除与开腹肝切除的疗效比较:一项回顾性研究
Ann Gastroenterol Surg. 2021 Sep 16;6(1):135-148. doi: 10.1002/ags3.12506. eCollection 2022 Jan.
5
Influence of obesity on in-hospital and postoperative outcomes of hepatic resection for malignancy: a 10-year retrospective analysis from the US National Inpatient Sample.肥胖对恶性肿瘤肝切除术后住院及预后的影响:来自美国国家住院样本的10年回顾性分析
BMJ Open. 2019 Aug 27;9(8):e029823. doi: 10.1136/bmjopen-2019-029823.
6
Obesity as a surgical risk factor.肥胖作为一种手术风险因素。
Ann Gastroenterol Surg. 2017 Oct 28;2(1):13-21. doi: 10.1002/ags3.12049. eCollection 2018 Jan.
7
Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B.接受恩替卡韦治疗慢性乙型肝炎患者中的肥胖与肝细胞癌
Clin Mol Hepatol. 2016 Sep;22(3):339-349. doi: 10.3350/cmh.2016.0021. Epub 2016 Sep 25.
8
Upper abdominal shape as a risk factor of extended operation time and severe postoperative complications in HCC hepatectomy through subcostal incision.上腹部形态作为经肋下切口行肝癌肝切除术时延长手术时间及严重术后并发症的危险因素。
World J Surg Oncol. 2015 Oct 13;13:298. doi: 10.1186/s12957-015-0702-7.
9
The Association Between Body Mass Index and the Prognosis and Postoperative Complications of Hepatocellular Carcinoma: A Meta-Analysis.体重指数与肝细胞癌预后及术后并发症的关系:一项荟萃分析
Medicine (Baltimore). 2015 Aug;94(31):e1269. doi: 10.1097/MD.0000000000001269.
10
Obesity Does Not Influence Outcomes in Hepatocellular Carcinoma Patients following Curative Hepatectomy.肥胖不影响肝细胞癌患者根治性肝切除术后的预后。
PLoS One. 2015 May 12;10(5):e0125649. doi: 10.1371/journal.pone.0125649. eCollection 2015.

本文引用的文献

1
Obesity rather than neoadjuvant chemotherapy predicts steatohepatitis in patients with colorectal metastasis.肥胖而非新辅助化疗预测结直肠转移患者的脂肪性肝炎。
Am J Surg. 2013 Jun;205(6):685-90. doi: 10.1016/j.amjsurg.2012.07.034. Epub 2013 Feb 4.
2
The effect of overweight status on the short-term and 20-y outcomes after hepatic resection in patients with hepatocellular carcinoma.超重状态对肝细胞癌患者肝切除术后短期和 20 年结局的影响。
J Surg Res. 2012 Dec;178(2):640-5. doi: 10.1016/j.jss.2012.05.063. Epub 2012 Jun 12.
3
Safety of hepatic resections in obese veterans.肥胖退伍军人肝切除术的安全性
Arch Surg. 2012 Apr;147(4):331-7. doi: 10.1001/archsurg.2011.1404. Epub 2011 Dec 19.
4
Obesity, inflammation, and liver cancer.肥胖、炎症与肝癌。
J Hepatol. 2012 Mar;56(3):704-13. doi: 10.1016/j.jhep.2011.09.020. Epub 2011 Nov 25.
5
Secular trends in the prevalence of general and abdominal obesity among Chinese adults, 1993-2009.1993-2009 年中国成年人一般和腹型肥胖流行率的变化趋势。
Obes Rev. 2012 Mar;13(3):287-96. doi: 10.1111/j.1467-789X.2011.00944.x. Epub 2011 Oct 31.
6
Negative impact of low body mass index on surgical outcomes after hepatectomy for hepatocellular carcinoma.低体重指数对肝癌肝切除术后手术结果的负面影响。
J Hepatobiliary Pancreat Sci. 2012 Jul;19(4):449-57. doi: 10.1007/s00534-011-0461-y.
7
Safety of hepatic resection in overweight and obese patients with cirrhosis.肝切除术治疗超重和肥胖合并肝硬化患者的安全性。
Br J Surg. 2011 Aug;98(8):1147-54. doi: 10.1002/bjs.7516. Epub 2011 Apr 20.
8
Liver resection in obese patients: results of a case-control study.肥胖患者的肝切除术:一项病例对照研究的结果。
HPB (Oxford). 2011 Feb;13(2):103-11. doi: 10.1111/j.1477-2574.2010.00252.x. Epub 2010 Dec 22.
9
Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS).术后肝衰竭:国际肝脏外科研究组织(ISGLS)的定义和分级。
Surgery. 2011 May;149(5):713-24. doi: 10.1016/j.surg.2010.10.001. Epub 2011 Jan 14.
10
Novel and simple preoperative score predicting complications after liver resection in noncirrhotic patients.新型且简单的术前评分可预测非肝硬化患者肝切除术后的并发症。
Ann Surg. 2010 Nov;252(5):726-34. doi: 10.1097/SLA.0b013e3181fb8c1a.